Heights Capital Management’s Imunon IMNN Stock Holding History
Bought
Maintained
Sold
Other funds holding IMNN
Heights Capital Management's IMNN Position: Q2 2021 in Review
Heights Capital Management sold out of Imunon (IMNN) in Q2 2021, closing a stake of 1,727 shares — an estimated $466K sold.
Heights Capital Management first reported a position in IMNN in Q1 2020 and held it in 2 quarters. The position peaked at $1.03M in Q1 2020. 37 funds tracked by Wall St. Rank hold IMNN as of Q2 2021.
- Heights Capital Management reported no remaining Imunon position as of Q2 2021 after selling out during the quarter.
- Heights Capital Management sold 1,727 Imunon shares in Q2 2021, an estimated $466K.
- Heights Capital Management first reported a position in Imunon in Q1 2020 and held it in 2 quarters.
- Heights Capital Management's Imunon position peaked at $1.03M in Q1 2020.
- 37 funds tracked by Wall St. Rank held Imunon as of Q2 2021.
Based on Heights Capital Management's 13F filing for Q2 2021, filed 11 Aug 2021.